Bristol Myers Squibb

Bristol Myers Squibb

6

Total Publications

1

Abstract/Manuscript

5

Poster Presentation

2024 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World Results From TARGET-IBD

2024 · Poster Presentation · Wake Forest University School of Medicine · Gastroenterology

Time to Diagnosis Among Patients with Eosinophilic Esophagitis in the United States

2023 · Poster Presentation · University of Chicago · Gastroenterology

Outcomes of early vs. delayed advanced therapy among patients with moderate ulcerative colitis in the United States: TARGET-IBD

2022 · Poster Presentation · Bristol Myers Squibb · Gastroenterology

Treatment patterns among moderate-to-severe ulcerative colitis patients in TARGET-IBD

2021 · Poster Presentation · University of North Carolina at Chapel Hill · Gastroenterology

Histological Inflammation Predicts Loss of Remission Among Crohn's Patients with Endoscopic Remission: A US Cohort Analysis

2020 · Poster Presentation · Atrium Health · Gastroenterology

Factors Associated with Biologic Discontinuation in Patients with Inflammatory Bowel Disease in TARGET-IBD

TARGET PharmaSolutions Announces Partnership with Bristol Myers Squibb to Advance Inflammatory Bowel Disease (IBD) Research

Bristol-Myers Squibb (BMY) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH

TARGET PharmaSolutions Partners with Bristol-Myers Squibb, Offering a New Platform to Collect Real World Data